{
  "id": "54f35ad864850a5854000004",
  "type": "factoid",
  "question": "LY450139 is investigational name of which drug?",
  "ideal_answer": "LY450139 is investigational name of Semagacestat. It is a \u03b3-secretase inhibitor developed for treatment for Alzheimer's disease. Chemical name of LY450139 is hydroxylvaleryl monobenzocaprolactam.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/19692615",
    "http://www.ncbi.nlm.nih.gov/pubmed/20350302",
    "http://www.ncbi.nlm.nih.gov/pubmed/22710916",
    "http://www.ncbi.nlm.nih.gov/pubmed/22018341",
    "http://www.ncbi.nlm.nih.gov/pubmed/23278303",
    "http://www.ncbi.nlm.nih.gov/pubmed/19527190",
    "http://www.ncbi.nlm.nih.gov/pubmed/22778845",
    "http://www.ncbi.nlm.nih.gov/pubmed/20634579"
  ],
  "snippets": [
    {
      "text": "The outcomes of the clinical trials of the \u03b3-secretase inhibitor Semagacestat (LY-450139) and the \u03b3-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the \u03b3-secretase era. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22710916",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A selective BACE inhibitor and the \u03b3-secretase inhibitor LY450139 (semagacestat) were used to inhibit respective secretase.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22018341",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22778845",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Semagacestat (LY450139) is a novel \u03b3-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22778845",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The \u03b3-secretase inhibitor LY450139 (semagacestat) lowers plasma A\u03b2(1-40) and A\u03b2(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20634579",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TRODUCTION: LY450139 (semagacestat) inhibits gamma-secretase, a key enzyme for generation of amyloid beta (Abeta), the peptide deposited in plaques in Alzheimer disease (AD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20350302",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two potent gamma-secretase inhibitors (GSIs), DAPT (N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester) and LY450139 (hydroxylvaleryl monobenzocaprolactam), were found to reduce the density of dendritic spines in wild-type mice. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19692615",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "velopment of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19527190",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "OBJECTIVE: This paper reviews the pharmacology and chemical efficacy of an A beta-lowering agent, semagacestat (LY450139).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19527190",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22778845",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " A selective BACE inhibitor and the \u03b3-secretase inhibitor LY450139 (semagacestat) were used to inhibit respective secretase.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22018341",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015507"
  ],
  "exact_answer": "semagacestat"
}